Discontinued — last reported Q4 '21
Business Segments · Total Assets
Healthcare and Life Sciences — Total Assets
STERIS Healthcare and Life Sciences — Total Assets decreased by 0.4% to $5.37B in Q4 2021 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2020
Last reportedQ4 2021
Rolls up toTotal Assets
How to read this metric
An increase generally signals business expansion or investment in production capacity, whereas a decrease may indicate asset divestitures or depreciation outpacing capital investment.
Detailed definition
This metric represents the total economic resources controlled by the Healthcare and Life Sciences segment, including pr...
Peer comparison
Similar to total segment assets reported by other diversified medical device and life sciences companies, reflecting the scale of their manufacturing and service infrastructure.
Metric ID:
ste_segment_healthcare_and_life_sciences_assetsHistorical Data
3 periods
| Q2 '21 | Q3 '21 | Q4 '21 | |
|---|---|---|---|
| Value | $5.43B | $5.40B | $5.37B |
| QoQ Change | — | -0.5% | -0.4% |
Range$5.37B – $5.43B
Current Streak2+ quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is STERIS's healthcare and life sciences — total assets?
- STERIS (STE) reported healthcare and life sciences — total assets of $5.37B in Q4 2021.
- What does healthcare and life sciences — total assets mean?
- The total value of resources and equipment owned by the Healthcare and Life Sciences business segment.